Clinical Trials Directory

Trials / Unknown

UnknownNCT01360892

Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography

Prediction of Incidence of Liver Cancer or PorTal Hypertension in Patients With Viral Hepatitis by Use of Real-time Tissue Elastography

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Kindai University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This is a multi-center cohort study in which the Real-time Tissue Elastography® measurements will predict prospectively the incidence of hepatocellular carcinoma, the incidence and severity of gastroesophageal varices ascites and decompensated cirrhosis in hepatitis B or C patients.

Detailed description

The aim of this study is to validate the predictive value of Real-time Tissue Elastography® by comparison with serum marker or FibroScan® in chronic hepatitis B or C patients. Every year and for three years, we performed Real-time Tissue Elastography®, blood sampling, gastrointestinal endoscopy. If in the hospital they can perform FibroScan®, FobroScan® also be performed. Subjects were also performed ultrasonography (US), computed sonography (CT) or magnetic resonance imaging (MRI) evry four or six months. The time between the Real-time Tissue Elastography®, blood sampling, gastrointestinal endoscopy and FiroScan® must not exceed four weeks.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2013-08-01
Completion
2013-09-01
First posted
2011-05-26
Last updated
2011-05-26

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01360892. Inclusion in this directory is not an endorsement.